Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 925 | 2,417 | 4,983 | 1,438 | 793 |
| Gross Profit | 925 | 2,417 | 4,983 | 1,438 | 793 |
| Operating Expenses | 1,623 | 2,942 | 3,406 | 1,875 | 1,488 |
| Operating Income | -698 | -524 | 1,576 | -437 | -695 |
| Other Income | 0 | -1 | 1 | 0 | 0 |
| Pre-tax Income | -698 | -525 | 1,577 | -437 | -695 |
| Net Income Continuous | -698 | -525 | 1,577 | -437 | -695 |
| Net Income | $-698 | $-525 | $1,577 | $-437 | $-695 |
| EPS Basic Total Ops | -0.01 | N/A | 0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.01 | N/A | 0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-698 | $-525 | $1,577 | $-437 | $-695 |